ArticleInflammopharmacology2026
Chemical characterization, antioxidant activity, and effects of Moroccan monofloral honeys on ovalbumin induced asthma in rats.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Honey has been traditionally used for the management of respiratory disorders, including asthma, yet its mechanistic relevance in allergic airway inflammation remains insufficiently clarified. The present study investigated the chemical composition, antioxidant capacity, and anti-inflammatory effects of two Moroccan monofloral honeys, Ziziphus lotus (L.) Lam and Eryngium campestre L., in a rat model of ovalbumin (OVA)-induced allergic asthma, and explored potential molecular interactions of major phenolic constituents with key signaling proteins involved in disease pathophysiology. Physicochemical properties were determined according to standard methods. Total phenolic and flavonoid compounds (TPC and TFC) were quantified using colorimetric assays, while ascorbic acid content was determined by titrimetric analysis. Phenolic profiles were characterized by high-performance liquid chromatography, and antioxidant activity was assessed using radical-scavenging and total antioxidant capacity assays. In vivo effects were evaluated through hematological analysis, immunoglobulin E (IgE) quantification, bronchoalveolar lavage cellularity, and histopathological examination. Both honeys met international quality standards and exhibited distinct phenolic signatures. Eryngium campestre L. honey showed higher phenolic and flavonoid contents and stronger antioxidant activity compared with Ziziphus lotus (L.) Lam honey. OVA sensitization induced a marked leukocyte infiltration and elevated the IgE levels, whereas honey supplementation reduced significantly inflammatory cell counts and IgE concentrations and preserved lung architecture. Molecular docking indicated the favorable interactions of quercetin and kaempferol with spleen tyrosine kinase (SYK), mitogen-activated protein kinase 3 (MAPK3), and signal transducer and activator of transcription 6 (STAT6). These findings suggest that Moroccan monofloral honeys exert antioxidant and immunomodulatory effects and may attenuate allergic airway inflammation through the modulation of the key inflammatory signaling pathways.
Indexed as
Identifiers
42771299What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.